A cost-consequence analysis of a menu intervention in early childhood education and care

被引：0
|
作者：
Kurkela, Olli [1 ,2 ]
Virtanen, S. M. [2 ]
Erkkola, M. [3 ]
Saarinen, M. [4 ]
Niinisto, S. [2 ]
Raulio, S. [2 ]
Ahokas, I. [3 ]
Meinila, J. [3 ]
Forma, L. [1 ]
机构：
[1] Laurea Univ Appl Sci, Vantaa, Finland
[2] Finnish Inst Hlth & Welf, Helsinki, Finland
[3] Univ Helsinki, Helsinki, Finland
[4] Nat Resources Inst Finland, Helsinki, Finland
来源：
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2023年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
ckad160.10
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea
    Cha, Seungju
    Sohn, Minjeong
    Yang, Hyowon
    Yeh, Eric J.
    Baek, Ki-Hyun
    Ha, Jeonghoon
    Ku, Hyemin
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [42] COST-CONSEQUENCE ANALYSIS OF TROPONIN T SCREENING ON THE DETECTION OF PERIOPERATIVE MYOCARDIAL ISCHEMIA
    Buse, G. A. Lurati
    Manns, B.
    Lamy, A.
    Devereaux, P.
    [J]. ANESTHESIA AND ANALGESIA, 2013, 116 : 119 - 119
  • [43] Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients
    Ramirez, Manuel G.
    Niu, Xiaoli
    Epstein, Josh
    Yang, Dongyan
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (10) : 1041 - 1046
  • [44] A comparative cost-consequence analysis of TNF antagonists in the treatment of psoriatic arthritis.
    Nosyk, B
    Guh, D
    Bansback, N
    Melilli, L
    Anis, A
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S672 - S672
  • [45] A cost-consequence analysis of normalised advance care planning practices among people with chronic diseases in hospital and community settings
    Sarah Jeong
    Se Ok Ohr
    Peter Cleasby
    Tomiko Barrett
    Ryan Davey
    Simon Deeming
    [J]. BMC Health Services Research, 21
  • [46] End-of-life care for nursing home residents with advanced dementia and feeding problems: A cost-consequence analysis.
    Caprio, T. V.
    Holloway, R. G.
    McCann, R.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S200 - S200
  • [47] PROPHYLAXIS WITH RIVAROXABAN AGAINST VENOUS THROMBOEMBOLISM (VTE): A COST-CONSEQUENCE ANALYSIS FROM THE PERSPECTIVE OF THE ITALIAN HEALTH CARE SERVICE
    Negrini, C.
    Diamantopoulos, A.
    Forster, F.
    Lopatriello, S.
    Lees, M.
    Bianchi, C.
    Pedone, M. P.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A534 - A534
  • [48] SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
    Emilie Fargier
    Florence Ranchon
    Laure Huot
    Pascale Guerre
    Violaine Safar
    Arthur Dony
    Nathalie Hequet
    Emmanuel Bachy
    Stéphane Savouroux
    Clémentine Fronteau
    Patrick Tomaré
    Jean-François Tournamille
    Vérane Schwiertz
    Nicolas Vantard
    Steven Le Gouill
    Emmanuel Gyan
    Gilles Salles
    Catherine Rioufol
    [J]. Annals of Hematology, 2018, 97 : 123 - 131
  • [49] A cost-consequence analysis of normalised advance care planning practices among people with chronic diseases in hospital and community settings
    Jeong, Sarah
    Ohr, Se Ok
    Cleasby, Peter
    Barrett, Tomiko
    Davey, Ryan
    Deeming, Simon
    [J]. BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [50] SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
    Fargier, Emilie
    Ranchon, Florence
    Huot, Laure
    Guerre, Pascale
    Safar, Violaine
    Dony, Arthur
    Hequet, Nathalie
    Bachy, Emmanuel
    Savouroux, Stphane
    Fronteau, Clementine
    Tomare, Patrick
    Tournamille, Jean-Francois
    Schwiertz, Verane
    Vantard, Nicolas
    Le Gouill, Steven
    Gyan, Emmanuel
    Salles, Gilles
    Rioufol, Catherine
    [J]. ANNALS OF HEMATOLOGY, 2018, 97 (01) : 123 - 131
12345